Craft
  • Home
  •  / Oncoceutics
Oncoceutics

Oncoceutics

Oncoceutics Summary

Company summary

Overview
Oncoceutics is a drug discovery and development company focused on selective G protein-coupled receptor antagonists for oncology. It offers ONC201, an orally active DRD2 small molecule antagonist that can be used against advanced cancers.
Type
Private
Founded
2009
HQ
Philadelphia, PA, US | view all locations
Website
https://oncoceutics.com
Cybersecurity rating
Sectors

Key people

  • Lee Schalop

    Lee Schalop, Chief Executive Officer and Director

    • Martin Stogniew

      Martin Stogniew, Chief Development Officer and Director

      • Sebastian Franzinger

        Sebastian Franzinger, Vice President, Finance and Business Development

        • Joshua Allen

          Joshua Allen, Chief Scientific Officer

          LocationsView all

          2 locations detected

          • Philadelphia, PA HQ

            United States

            3675 Market St #200

          • New York, NY

            United States

            1460 Broadway

          Footer menu